Literature DB >> 7957063

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.

U Zimber-Strobl1, L J Strobl, C Meitinger, R Hinrichs, T Sakai, T Furukawa, T Honjo, G W Bornkamm.   

Abstract

Epstein-Barr virus nuclear antigen 2 (EBNA-2) plays a crucial role in B cell immortalization by Epstein-Barr virus (EBV), most probably by its ability to transactivate several cellular and viral genes. Recently, we showed that EBNA-2 interacts with the TP1 promoter of EBV through a cellular protein. In this report we provide evidence that this protein is recombination signal binding protein (RBP)-J kappa, highly conserved in evolution, and originally isolated by its ability to bind to the J kappa-type V(D)J recombination signal sequence. To identify the cellular protein interacting with the TP1 promoter, we performed electrophoretic mobility shift assays using binding sequences of known transcription factors, that carry partial homology to the crucial sequences of the EBNA-2 responsive element (EBNA-2RE), as competitor. Competition assays revealed the RBP-J kappa recognition site as a very efficient competitor of cellular TP1 promoter binding protein. In parallel, we purified the protein to homogeneity from Raji cells by two ion-exchange columns and affinity purification using the EBNA-2RE coupled to magnetic beads. Affinity purified fractions separated on SDS-PAGE revealed a single predominant band after silver staining which was recognized by anti-RBP-J kappa monoclonal antibody. These purified fractions exhibited binding specificity for EBNA-2RE and EBNA-2. In vitro-translated murine RBP-2 cDNA reacted with EBNA-2RE and EBNA-2 in the same fashion as the affinity purified protein. The interaction between RBP-J kappa and EBNA-2 is a prerequisite for EBNA-2-mediated transactivation of the TP1 promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957063      PMCID: PMC395438          DOI: 10.1002/j.1460-2075.1994.tb06824.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas.

Authors:  D H Crawford; M A Epstein; G W Bornkamm; B G Achong; S Finerty; J L Thompson
Journal:  Int J Cancer       Date:  1979-09-15       Impact factor: 7.396

Review 3.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

4.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

Authors:  S W Hiebert; M Lipp; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

Authors:  A Calender; M Billaud; J P Aubry; J Banchereau; M Vuillaume; G M Lenoir
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.

Authors:  M J Allday; D H Crawford; B E Griffin
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

7.  A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif.

Authors:  N Matsunami; Y Hamaguchi; Y Yamamoto; K Kuze; K Kangawa; H Matsuo; M Kawaichi; T Honjo
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

8.  Purification and characterization of a protein that binds to the recombination signal sequence of the immunoglobulin J kappa segment.

Authors:  Y Hamaguchi; N Matsunami; Y Yamamoto; T Honjo
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

9.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.

Authors:  C Rooney; J G Howe; S H Speck; G Miller
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

View more
  102 in total

1.  A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; S D Hayward
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.

Authors:  M Cotter; J Callahan; J Aster; E Robertson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.

Authors:  S Fujiwara; Y Nitadori; H Nakamura; T Nagaishi; Y Ono
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  The amino acid region 248-382 of the Epstein-Barr virus nuclear protein 2 (EBNA2) is responsible for the EBNA2-induced EBV reactivation.

Authors:  S Fujiwara; E Liu; K Shimizu
Journal:  Virus Genes       Date:  2001-12       Impact factor: 2.332

6.  Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.

Authors:  S Harada; R Yalamanchili; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors:  Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

8.  Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

Authors:  Nathalie Alazard; Henri Gruffat; Edwige Hiriart; Alain Sergeant; Evelyne Manet
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.

Authors:  Natalie Sutkowski; Gang Chen; German Calderon; Brigitte T Huber
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.